Search results
David A. Braun, MD, PhD. Principal Investigator. David is a physician-scientist, an Assistant Professor at the Yale School of Medicine, a Goodman and Gilman Yale Scholar, and a principal investigator in the Center of Molecular and Cellular Oncology within the Yale Cancer Center.
Clinical translation. Collaboratively translating our laboratory findings into early “signal-finding”, investigator-initiated phase 1 clinical trials to advance care for patients with advanced cancer. BraunLab. 300 George Street, Suite 6400.
Jun 5, 2023 · David A. Braun, MD, PhD My front-line ccRCC treatment paradigm* *DISCLAIMER: views are my own. Assumes clear cell RCC, patient who requires treatment (not active surveillance), no contraindication to IO, and IMDC intermediate/poor risk disease. Actual treatment decisions made collaboratively with the patient. IO + IO nivolumab + ipilimumab IO ...
Feb 15, 2024 · David Braun, MD, PhD, recalls a patient with metastatic renal cell carcinoma, who asked a simple yet impactful question, "Is the juice worth the squeeze?"
Jul 18, 2023 · The laboratory of David A. Braun, MD, PhD, has received approximately $5.75M in federal awards to fund mechanisms of response and resistance to immune therapy in kidney cancer at Yale Cancer Center.
David Braun, MD, PhD, is an Assistant Professor of Medicine (Medical Oncology) and a member of the Center of Molecular and Cellular Oncology (CMCO) at Yale Cancer Center. Dr. Dr. Braun cares for patients with kidney cancers.
People also ask
Who is David Braun?
Who is Dr Braun?
How will funding support a new research project in Dr Braun's lab?
May 7, 2024 · In this interview, David Braun, MD, PhD, and Patrick Kenney, MD, describe their practices and touch on unmet needs in kidney cancer treatment. Braun is an assistant professor of medicine (medical oncology) and of pathology and urology at Yale School of Medicine, New Haven, Connecticut as well as a Yale Cancer Center member. Kenney is an ...